Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial
Clicks: 109
ID: 278924
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
109 views
54 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #392 of 436 articles by views in Trials
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 436 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Type 2 diabetes mellitus (T2DM) and obesity are syndemic and will have a significant impact on affected individuals and healthcare services worldwide. Evidence shows that T2DM remission can be achieved with significant weight loss in those who are younger with early diabetes and requiring fewer medications for glycaemic control. DIADEM-I aims to examine the impact of an intensive lifestyle intervention (ILI) using a low-energy diet (LED) meal replacement approach combined with physical activity in younger individuals with early T2DM. Methods The planned study is an ongoing, non-blinded, pragmatic, randomised controlled, parallel-group trial examining the impact of an LED-based ILI on body weight and diabetes remission in younger (18–50 years) T2DM individuals with early diabetes (≤ 3-year duration). The ILI will be compared to usual medical care (UMC). The primary outcome will be weight loss at 12 months. Other key outcomes of interest include diabetes remission, glycaemic control, diabetes complications, cardiovascular health, physical activity, mental health, and quality of life. It is planned for the study to include 138 subjects for assessment of the primary outcome. Safety will be assessed throughout. Discussion If DIADEM-I demonstrates a clinically significant effect for younger individuals with early T2DM, it will inform clinical guidelines and services of the future for management of T2DM. Trial registration ISRCTN: ISRCTN20754766 (date assigned: 7 June 2017); ClinicalTrials.gov, ID: NCT03225339 Registered on 26 June 2017.
| Reference Key |
taheri2018diabetestrials
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Taheri, Shahrad;Chagoury, Odette;Zaghloul, Hadeel;Elhadad, Sara;Ahmed, Salma Hayder;Omar, Omar;Payra, Sherryl;Ahmed, Salma;Khatib, Neda El;Amona, Rasha Abou;Nahas, Katie El;Bolton, Matthew;Chaar, Henem;Suleiman, Noor;Jayyousi, Amin;Zirie, Mahmoud;Janahi, Ibrahim;Elhag, Wahiba;Alnaama, Abdulla;Zainel, Abduljaleel;Hassan, Dahlia;Cable, Tim;Charlson, Mary;Wells, Martin;Al-Hamaq, Abdulla;Al-Abdulla, Samya;Abou-Samra, Abdul Badi; |
| Journal | Trials |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.